Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call indicates strong revenue growth, improved financial metrics, and operational efficiencies. Despite some risks related to the facility move and federal research program lapse, the company has a positive demand outlook, new contracts, and potential market opportunities. The Q&A revealed management's confidence in handling cost pressures and future expansion. However, lack of specific guidance on new technologies and gold price impacts suggests some uncertainties. Overall, the positive aspects outweigh the negatives, suggesting a positive stock price movement in the near term.
Revenue for Q4 2025 $8.2 million, up from $5.9 million in Q4 2024, driven by strong product demand and higher shipments. However, revenue was down from Q3 levels due to extended holiday periods for customers, particularly overseas.
Gross Profit for Q4 2025 $1.2 million (14.6% of sales), compared to a gross loss of $0.3 million in Q4 2024. The increase was due to higher revenue and greater manufacturing efficiencies. Margins were lower than Q3 due to reduced revenue and the increased cost of gold, which diluted margins.
SG&A Expenses for Q4 2025 $1.3 million, up from $1.0 million in Q4 2024. The increase reflects active cost management while ramping up production and investing for growth.
Operating Loss for Q4 2025 Approximately $100,000, compared to $1.3 million in Q4 2024. The improvement was due to higher revenue and better cost management.
Net Income for Q4 2025 $12,000 ($0.00 per share), compared to a net loss of $1 million ($0.07 per share) in Q4 2024. The improvement was driven by increased revenue and operational efficiencies.
Cash and Marketable Securities at Year-End 2025 $4.5 million in cash and $8.8 million in marketable securities, compared to a combined total of $4.3 million at the beginning of 2025. The increase was due to a public offering that raised funds for growth and relocation.
Trade Accounts Receivable at Year-End 2025 $5.2 million, up from $3.3 million at the end of 2024, reflecting increased production and customer demand.
Liabilities (Payables and Accruals) at Year-End 2025 $4.3 million, up from $4.0 million at the end of 2024, reflecting increased operational activity.
HybridTech Armor: Orders supporting the U.S. Navy are expected to resume in the latter half of 2026, with funding secured for ballistic shields on a small quantity of U.S. Navy destroyers. Detailed contract negotiations are expected to begin soon.
AlMax product line: A newly installed higher capacity mill now allows processing of ceramic fiber at twice the previous rate, supporting customer engagement and business development efforts.
Controlled fragmentation tungsten warhead program: Phase 2 of this program, funded by the Army, is underway. A new sintering oven has been installed, enabling the production of 40-millimeter warhead samples designed to exceed Army performance benchmarks.
Radiation shielding: Research continues with ongoing funding from the DOE, focusing on developing and testing larger scale samples for lightweight MMC radiation shielding across multiple industries.
New manufacturing facility: Plans to relocate to a larger manufacturing facility to address space constraints and support long-term growth and product expansion. This move is expected to enhance operational efficiencies and enable revenue growth.
Revenue growth: Achieved record revenue of $32.6 million in 2025, driven by strong product demand and higher shipments.
Manufacturing efficiencies: Expanded production capabilities, including a fully operational third shift for metal matrix composite product manufacturing, contributing to higher revenue and improved asset utilization.
Cost management: Actively managing costs while ramping up production and investing for growth. SG&A expenses remained fairly constant throughout 2025.
Capital raise: Completed a secondary offering in Q4 2025, raising $9.5 million to strengthen the balance sheet and fund the move to a larger manufacturing facility.
Federal research programs: Received 13 awards from the Department of Defense and Department of Energy since 2021. Ongoing contracts continue to be funded, and reauthorization of federal programs is anticipated soon, which will support further research and development.
Geopolitical Events: The ongoing conflict in Ukraine, Israel, and the Middle East, along with other geopolitical events, poses uncertainties that could impact CPS' operations and environment.
Gold Cost Increases: Dramatically increased costs of gold are diluting margins, as the margin for added gold cost is nominally zero.
Facility Space Constraints: The current manufacturing facility is space-constrained, limiting the company's ability to respond to growing demand and expand revenue.
Federal Research Program Lapse: The lapse in federal SBIR and STTR programs due to lack of reauthorization by Congress has halted the review of submitted proposals and the publication of new research topics, potentially impacting CPS' federally supported research activities.
Operational Transition Risks: The planned relocation to a new manufacturing facility involves risks related to timing, operational disruptions, and the need for a smooth transition to maintain production and meet demand.
Revenue Growth: The company expects 2026 to be a year of solid revenue growth, supported by sustained strong demand for its products, expanded floor space, and the addition of targeted production equipment.
Manufacturing Facility Relocation: The company plans to relocate to a larger manufacturing facility in the coming months to address space constraints, improve operational efficiencies, and support long-term growth. The move is expected to enable increased revenue and targeted gross margin improvements.
HybridTech Armor Orders: Orders supporting the U.S. Navy are expected to resume in the latter half of 2026, with funding secured for ballistic shields on a small quantity of destroyers. Detailed contract negotiations are anticipated in the coming months.
Federal Research Programs: The company anticipates the reauthorization of federal SBIR and STTR programs, which will enable the publication of new research topics and the review of pending applications. This is expected to support ongoing and future federally funded research activities.
Product Development and Market Expansion: Investments in capital equipment and new facility space are expected to accelerate product development, strengthen competitive positioning, and enable commercialization of emerging product lines, including radiation shielding and advanced materials for defense applications.
The selected topic was not discussed during the call.
The earnings call indicates strong revenue growth, improved financial metrics, and operational efficiencies. Despite some risks related to the facility move and federal research program lapse, the company has a positive demand outlook, new contracts, and potential market opportunities. The Q&A revealed management's confidence in handling cost pressures and future expansion. However, lack of specific guidance on new technologies and gold price impacts suggests some uncertainties. Overall, the positive aspects outweigh the negatives, suggesting a positive stock price movement in the near term.
The earnings call summary reveals strong financial performance with significant revenue growth and improved profitability. However, the Q&A section highlights potential risks, such as military spending uncertainty and short-term margin pressures due to new hires. The company's strategic moves, like facility relocation and ALMAX opportunities, offer growth potential but are not immediate catalysts. Given the mixed signals, including the impact of vendor shutdowns on Q4 revenue, the overall sentiment is neutral, balancing positive financials with potential risks and uncertainties.
CPS reported a strong financial performance with a 27% revenue increase and a turnaround to profitability. The company's optimistic guidance, expansion plans, and margin improvement expectations are positive indicators. Despite some operational challenges and geopolitical risks, the market's focus is likely on CPS's growth prospects and strong demand. The lack of a share repurchase program is a minor negative, but the overall sentiment from the earnings call and Q&A session is positive.
The earnings call reveals strong financial performance with a 27% revenue increase and a return to profitability, despite some challenges. Product development and market expansion are promising, with new contracts and strong demand. However, geopolitical and economic risks, as well as supply chain and staffing issues, pose concerns. The Q&A session indicates cautious optimism with ongoing partnerships and potential new opportunities. The lack of shareholder return programs is a downside, but the overall outlook is positive, expecting margin improvements and continued growth.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.